Safety and Efficacy of Genolimzumab (GB226) in Combination With Fruquintinib

Clinical trial NCT03976856 · UNKNOWN

Trial details

NCT number: NCT03976856
Sponsor: Genor Biopharma Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Non-small Cell Lung Cancer

Start date: 2019-07-23
Primary completion: 2021-12-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.